MENU
PMN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Promis Neurosciences (PMN) Ownership - Who owns Promis Neurosciences?

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA)... Show more

Profile

Industry
N/A
Address
1920 Yonge Street
Phone
+1 416 847-6898
Employees
11
Web
https://www.promisneurosciences.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
95.51M
P/E Ratio
7.78
Total Cash
53.46M
Projected Growth
N/A
Total Debt
4.05M
Revenue
N/A
Risk (Beta)
-0.92
Dividend Yield
N/A
Total Cash/Share
5.96
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Promis Neurosciences? PMN symbol Ownership - Tickeron.com